• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

达托霉素对葡萄球菌属在塑料载体上形成的生物膜的活性

Activity of daptomycin on biofilms produced on a plastic support by Staphylococcus spp.

作者信息

Roveta S, Marchese A, Schito G C

机构信息

Sezione di Microbiologia, Di.S.C.A.T., University of Genoa, Largo R. Benzi 10, 16132 Genoa, Italy.

出版信息

Int J Antimicrob Agents. 2008 Apr;31(4):321-8. doi: 10.1016/j.ijantimicag.2007.11.012. Epub 2008 Feb 21.

DOI:10.1016/j.ijantimicag.2007.11.012
PMID:18201873
Abstract

The aim of this study was to assess whether the novel lipopeptide daptomycin might be capable of disrupting or inhibiting the synthesis of biofilms produced by staphylococci. Fourteen recently isolated slime-producing methicillin-susceptible (MET-S) and methicillin-resistant (MET-R) strains (three MET-S Staphylococcus aureus, three MET-R S. aureus, three MET-S Staphylococcus epidermidis, three MET-R S. epidermidis and two vancomycin-intermediate S. aureus (VISA)) were tested. Slime formation on polystyrene plates was quantified spectrophotometrically. Daptomycin (2-64 mg/L) inhibited slime synthesis by > or =80% in MET-S strains, by 60-80% in MET-R S. aureus and by 70-95% in MET-R S. epidermidis. At 64 mg/L, biofilm synthesis decreased by 80% in the VISA isolates. Daptomycin also disrupted pre-formed biofilm: >50% breakdown of initial biofilm (5h) was observed in all strains. Disruption of mature biofilms (48 h), in terms of percentage, was more variable depending on the strain, ranging from ca. 20% in a MET-R S. epidermidis strain to almost 70% in two MET-S strains (one S. aureus and one S. epidermidis). Daptomycin at concentrations achievable during therapy promoted a statistically significant inhibition of slime synthesis (preventing biofilm building) and induced slime disruption (disaggregating its structure) both in initial and mature biofilms on a plastic support in all staphylococcal strains studied.

摘要

本研究的目的是评估新型脂肽达托霉素是否能够破坏或抑制葡萄球菌产生的生物膜的合成。对14株最近分离出的产黏液的甲氧西林敏感(MET-S)和甲氧西林耐药(MET-R)菌株(3株MET-S金黄色葡萄球菌、3株MET-R金黄色葡萄球菌、3株MET-S表皮葡萄球菌、3株MET-R表皮葡萄球菌和2株万古霉素中介金黄色葡萄球菌(VISA))进行了测试。通过分光光度法定量测定聚苯乙烯平板上的黏液形成情况。达托霉素(2 - 64 mg/L)在MET-S菌株中抑制黏液合成>或 = 80%,在MET-R金黄色葡萄球菌中抑制60 - 80%,在MET-R表皮葡萄球菌中抑制70 - 95%。在64 mg/L时,VISA分离株中的生物膜合成减少了80%。达托霉素还能破坏预先形成的生物膜:在所有菌株中均观察到初始生物膜(5小时)有>50%的分解。就百分比而言,成熟生物膜(48小时)的破坏情况因菌株而异,范围从MET-R表皮葡萄球菌菌株中的约20%到两株MET-S菌株(一株金黄色葡萄球菌和一株表皮葡萄球菌)中的近70%。在本研究的所有葡萄球菌菌株中,治疗期间可达到的浓度的达托霉素在塑料载体上对初始和成熟生物膜均促进了黏液合成的统计学显著抑制(防止生物膜形成)并诱导了黏液破坏(分解其结构)。

相似文献

1
Activity of daptomycin on biofilms produced on a plastic support by Staphylococcus spp.达托霉素对葡萄球菌属在塑料载体上形成的生物膜的活性
Int J Antimicrob Agents. 2008 Apr;31(4):321-8. doi: 10.1016/j.ijantimicag.2007.11.012. Epub 2008 Feb 21.
2
A combined pharmacodynamic quantitative and qualitative model reveals the potent activity of daptomycin and delafloxacin against Staphylococcus aureus biofilms.联合药效定量和定性模型揭示达托霉素和德拉沙星对金黄色葡萄球菌生物膜的强大活性。
Antimicrob Agents Chemother. 2013 Jun;57(6):2726-37. doi: 10.1128/AAC.00181-13. Epub 2013 Apr 9.
3
Efficacy of daptomycin versus vancomycin in an experimental model of foreign-body and systemic infection caused by biofilm producers and methicillin-resistant Staphylococcus epidermidis.达托霉素与万古霉素治疗生物膜形成菌和耐甲氧西林表皮葡萄球菌致异物及全身感染的实验模型疗效比较。
Antimicrob Agents Chemother. 2012 Feb;56(2):613-7. doi: 10.1128/AAC.05606-11. Epub 2011 Nov 28.
4
[In vitro effect of vancomycin and daptomycin on biofilm formation of coagulase-negative staphylococci strains].[万古霉素和达托霉素对凝固酶阴性葡萄球菌菌株生物膜形成的体外作用]
Mikrobiyol Bul. 2017 Jul;51(3):220-235. doi: 10.5578/mb.57435.
5
Effects of demethylfruticuline A and fruticuline A from Salvia corrugata Vahl. on biofilm production in vitro by multiresistant strains of Staphylococcus aureus, Staphylococcus epidermidis and Enterococcus faecalis.皱边丹参中的去甲基紫堇达明碱 A 和紫堇达明碱 A 对耐多药金黄色葡萄球菌、表皮葡萄球菌和粪肠球菌生物膜形成的体外影响。
Int J Antimicrob Agents. 2011 Feb;37(2):129-34. doi: 10.1016/j.ijantimicag.2010.10.016. Epub 2010 Dec 15.
6
Activity of daptomycin- and vancomycin-loaded poly-epsilon-caprolactone microparticles against mature staphylococcal biofilms.载有达托霉素和万古霉素的聚ε-己内酯微粒对成熟葡萄球菌生物膜的活性。
Int J Nanomedicine. 2015 Jul 7;10:4351-66. doi: 10.2147/IJN.S84108. eCollection 2015.
7
activities of telithromycin against biofilms compared with azithromycin, clindamycin, vancomycin and daptomycin.比较了替利霉素与阿奇霉素、克林霉素、万古霉素和达托霉素对生物膜的活性。
J Med Microbiol. 2020 Jan;69(1):120-131. doi: 10.1099/jmm.0.001122.
8
Antibacterial and anti-biofilm activities of thiazolidione derivatives against clinical staphylococcus strains.噻唑烷二酮衍生物对临床葡萄球菌菌株的抗菌及抗生物膜活性
Emerg Microbes Infect. 2015 Jan;4(1):e1. doi: 10.1038/emi.2015.1. Epub 2015 Jan 7.
9
Observed Antagonistic Effect of Linezolid on Daptomycin or Vancomycin Activity against Biofilm-Forming Methicillin-Resistant Staphylococcus aureus in an In Vitro Pharmacodynamic Model.在体外药效学模型中观察到利奈唑胺对达托霉素或万古霉素抗生物膜形成耐甲氧西林金黄色葡萄球菌活性的拮抗作用。
Antimicrob Agents Chemother. 2015 Dec;59(12):7790-4. doi: 10.1128/AAC.01604-15. Epub 2015 Sep 14.
10
Evolution of Daptomycin Resistance in Coagulase-Negative Staphylococci Involves Mutations of the Essential Two-Component Regulator WalKR.凝固酶阴性葡萄球菌中达托霉素耐药性的进化涉及必需双组分调控器 WalKR 的突变。
Antimicrob Agents Chemother. 2019 Feb 26;63(3). doi: 10.1128/AAC.01926-18. Print 2019 Mar.

引用本文的文献

1
Novel approaches for the treatment of methicillin-resistant Staphylococcus aureus: Using nanoparticles to overcome multidrug resistance.治疗耐甲氧西林金黄色葡萄球菌的新方法:利用纳米颗粒克服多药耐药性。
Drug Discov Today. 2021 Jan;26(1):31-43. doi: 10.1016/j.drudis.2020.10.011. Epub 2020 Oct 20.
2
The biofilm eradication activity of acetic acid in the management of periprosthetic joint infection.乙酸在人工关节周围感染管理中的生物膜根除活性。
Bone Joint Res. 2018 Sep 15;7(8):517-523. doi: 10.1302/2046-3758.78.BJR-2018-0045.R1. eCollection 2018 Aug.
3
Newer antibiotics for the treatment of peritoneal dialysis-related peritonitis.
用于治疗腹膜透析相关性腹膜炎的新型抗生素。
Clin Kidney J. 2016 Aug;9(4):616-23. doi: 10.1093/ckj/sfw059. Epub 2016 Jul 4.
4
Exopolysaccharide biosynthetic glycoside hydrolases can be utilized to disrupt and prevent Pseudomonas aeruginosa biofilms.多糖生物合成糖苷水解酶可用于破坏和阻止铜绿假单胞菌生物膜的形成。
Sci Adv. 2016 May 20;2(5):e1501632. doi: 10.1126/sciadv.1501632. eCollection 2016 May.
5
Assessment of the Antimicrobial Activity of Algae Extracts on Bacteria Responsible of External Otitis.藻类提取物对引起外耳道炎的细菌的抗菌活性评估。
Mar Drugs. 2015 Oct 20;13(10):6440-52. doi: 10.3390/md13106440.
6
Antimicrobial activity of synthetic cationic peptides and lipopeptides derived from human lactoferricin against Pseudomonas aeruginosa planktonic cultures and biofilms.源自人乳铁蛋白的合成阳离子肽和脂肽对铜绿假单胞菌浮游培养物和生物膜的抗菌活性。
BMC Microbiol. 2015 Jul 7;15:137. doi: 10.1186/s12866-015-0473-x.
7
Evaluation of Ceftaroline Alone and in Combination against Biofilm-Producing Methicillin-Resistant Staphylococcus aureus with Reduced Susceptibility to Daptomycin and Vancomycin in an In Vitro Pharmacokinetic/Pharmacodynamic Model.在体外药代动力学/药效学模型中评估头孢洛林单独及联合使用对产生物膜的耐甲氧西林金黄色葡萄球菌的抗菌活性,该菌株对达托霉素和万古霉素敏感性降低
Antimicrob Agents Chemother. 2015 Aug;59(8):4497-503. doi: 10.1128/AAC.00386-15. Epub 2015 May 18.
8
Phenotypic and genotypic characterization of Staphylococci causing breast peri-implant infections in oncologic patients.肿瘤患者乳房植入物周围感染的葡萄球菌的表型和基因型特征
BMC Microbiol. 2015 Feb 10;15(1):26. doi: 10.1186/s12866-015-0368-x.
9
Dynamics of biofilm formation and the interaction between Candida albicans and methicillin-susceptible (MSSA) and -resistant Staphylococcus aureus (MRSA).白色念珠菌与甲氧西林敏感金黄色葡萄球菌(MSSA)及耐甲氧西林金黄色葡萄球菌(MRSA)之间生物膜形成的动态变化及相互作用。
PLoS One. 2015 Apr 13;10(4):e0123206. doi: 10.1371/journal.pone.0123206. eCollection 2015.
10
Evaluation of High-Dose Daptomycin Versus Vancomycin Alone or Combined with Clarithromycin or Rifampin Against Staphylococcus aureus and S. epidermidis in a Novel In Vitro PK/PD Model of Bacterial Biofilm.在一种新型细菌生物膜体外药代动力学/药效学模型中,评估高剂量达托霉素与单独使用万古霉素或联合克拉霉素或利福平治疗金黄色葡萄球菌和表皮葡萄球菌的效果。
Infect Dis Ther. 2014 Dec 18;4(1):51-65. doi: 10.1007/s40121-014-0055-5.